Immunic, Inc.
IMUX
$1.12
-$0.03-2.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.70% | -7.02% | 10.91% | -17.06% | 61.80% |
| Total Depreciation and Amortization | 52.17% | 23.53% | 40.91% | -18.75% | 21.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.34% | 13.38% | -28.35% | 283.81% | -95.91% |
| Change in Net Operating Assets | -98.83% | -57.79% | 42.31% | -223.36% | 1.98% |
| Cash from Operations | -63.71% | -20.17% | 14.74% | -22.84% | 7.13% |
| Capital Expenditure | 98.18% | -13.64% | -757.14% | 70.19% | -16,600.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 98.18% | -13.64% | -104.15% | -100.58% | 98.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.26% | -100.00% | -100.00% | 274.51% | -98.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -87.25% | -100.00% | -100.00% | 145,907.84% | -98.92% |
| Foreign Exchange rate Adjustments | -189.70% | 142.56% | -623.38% | 21.68% | -78.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.82% | -17.17% | -13.88% | 462.11% | -138.31% |